title: The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.
abstract: Prolonged neutropenia and chemotherapy-induced mucositis render patients with hematologic malignancies highly vulnerable to Gram-negative bacteremia. Unfortunately, multidrug-resistant (MDR) Gram-negative bacteria are increasingly encountered globally, and current guidelines for empirical antibiotic coverage in these patients may not adequately treat these bacteria. This expansion of resistance, coupled with traditional culturing techniques requiring 2-4 days for bacterial identification and antimicrobial susceptibility results, have grave implications for these immunocompromised hosts. This review characterizes the epidemiology, risk factors, resistance mechanisms, recommended treatments, and outcomes of the MDR Gram-negative bacteria that commonly cause infections in patients with hematologic malignancies. We also examine the infection prevention strategies in hematology patients, such as infection control practices, antimicrobial stewardship, and targeted decolonization. Finally, we assess the strategies to improve outcomes of the infected patients, including gastrointestinal screening to guide empirical antibiotic therapy, new rapid diagnostic tools for expeditious identification of MDR pathogens, and use of two new antimicrobial agents, ceftolozane/tazobactam and ceftazidime/avibactam.
authors.affiliation: a Division of Infectious Diseases , Weill Cornell Medicine , New York , NY , USA ;
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Baker
authors.affiliation: a Division of Infectious Diseases , Weill Cornell Medicine , New York , NY , USA ;|b Transplantation-Oncology Infectious Diseases Program , Weill Cornell Medicine , New York , NY , USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Satlin
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D006090:Gram-Negative Bacteria / Q000145:classification / Q000187:drug effects* / Q000235:genetics; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D019337:Hematologic Neoplasms / Q000150:complications* / Q000453:epidemiology; D006801:Humans; D017053:Infection Control; D017063:Outcome Assessment, Health Care
chemical_list: D000900:Anti-Bacterial Agents
keywords: Gram-negative bacteria; Hematologic malignancies; Multidrug-resistant